P202 | FRONTLINE NILOTINIB VS DASATINIB IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: A PROPENSITY SCORE ANALYSIS BASED ON AIFA MONITORING REGISTRIES

Frontline second generation tyrosine kinase inhibitors increased the rate of deep molecular responses (DMR) but were also mined by increased related adverse events. A single Asiatic trial randomized the two drugs, dasatinib and nilotinib without differences in efficacy. Aim: the aim of this analysi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	M. Breccia, P.P. Olimpieri, F. Pane, S. Celant, A. Iurlo, V. Summa, P. Corradini, P. Zinzani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ferrata Storti Foundation 2025-09-01
Edice:	Haematologica
On-line přístup:	https://haematologica.org/article/view/12399
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!